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Abstract 
Background: Social anxiety is prevalent in idiopathic Parkinson’s disease 
however why this is, is not yet well understood. Social cognitions, safety-
seeking behaviours and internally-focused attention are all known to predict 
social anxiety in the general population. These associated factors have not yet 
been explored idiopathic Parkinson’s disease, where disease severity and 
motor symptoms might also influence the experience of social anxiety. 
Aims: This study aimed to explore the relationship between cognitive-
behavioural factors and social anxiety in Parkinson’s disease.  
Method: Using a cross-sectional design, 124 people with Parkinson’s disease 
completed self-report questionnaires including measures of Parkinson’s disease 
severity, social anxiety, negative social cognitions, safety seeking behaviours, 
internally focused attention, anxiety and depression.  
Results: The final regression model accounted for 71.6% of variance in social 
anxiety. Cognitive-behavioural variables accounted for the largest magnitude of 
unique variance (43.5%). Sex, anxiety and depression accounted for 23.4%, 
and Parkinson non-motor symptom severity for 4.7%. Negative social cognitions 
and safety-seeking behaviours were statistically significant predictors while an 
internal focus of attention was not.  
Conclusions: Social anxiety in Parkinson’s disease is associated with negative 
social cognitions and safety-seeking behaviours. Findings indicate the need for 
further research into cognitive-behavioural approaches to social anxiety in 
Parkinson’s disease.  
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Social anxiety is one of the most commonly reported experiences of anxiety 
among people with Idiopathic Parkinson’s Disease (PwIDP).  Currently there is 
no specific guidance around the best clinical interventions to support PwIPD 
who experience social anxiety. This paper begins to explore the associated 
factors of social anxiety for PwIPD. It will contribute to the assessment of 
whether existing evidence based cognitive-behavioural approaches for social 
anxiety are applicable in this population. This paper will first introduce Idiopathic 
Parkinson’s Disease (IPD) and the prevalence of anxiety disorders. Existing 
cognitive-behavioural models of social anxiety are outlined before the specific 
area of social anxiety in IPD is discussed. 
 
Idiopathic Parkinson’s Disease (IPD) is a complex neurodegenerative condition 
that is not yet fully understood. Pathophysiological changes such as a loss of 
dopaminergic neurons in the basal ganglia, an area of the brain associated with 
voluntary motor movement, worsen over time (Stoker & Greenland, 2018). To 
establish a clinical diagnosis of IPD there must be evidence of Parkinsonism. 
Parkinsonism is defined by the presence of bradykinesia in combination with 
either muscular rigidity and/or resting tremor. These symptoms are assessed 
against a set of exclusion criteria and supportive positive criteria before a 
diagnosis can be made (Postuma et al., 2015). 
 
In addition to the physical presentation, there is increased recognition of non-
motor symptoms (NMS). Although it is proposed that these commonly present 
before the onset of motor symptoms (Chaudhuri, Healy, & Schapira, 2006), they 
are often overlooked at this early stage and not recognised as part of a complex 
neurodegenerative condition (Klingelhoefer & Reichmann, 2017). NMS include 
autonomic, sensory and sleep changes (Ishihara & Brayne, 2006). Anxiety and 
depression are also often conceptualised as NMS of IPD. While there are 
undoubtedly neurobiological changes associated with anxiety and depression, 
conceptualising both this way risks viewing such experiences as inevitable 
pathological consequences of IPD. In doing so, potentially treatable 
components of these understandable mental health responses to a challenging 
physical condition could be overlooked (Stephens, Dysch, & Gregory, 2018). 
Despite their substantial influence on disability and quality of life (Weintraub, 
Moberg, Duda, Katz, & Stern, 2004), NMS and mental health symptoms have 
received less attention than motor symptoms in IPD (Pachana et al., 2013). 
There is increasing demand for a better understanding of these important 
aspects through research (Deane et al., 2014). 
 
Prevalence of Mental Health Difficulties in PwIPD 
Existing research has highlighted that a range of mental health problems are 
frequently reported by PwIPD including generalised anxiety, low mood and 
social anxiety (Broen, Narayen, Kuijf, Dissanayaka, & Leentjens, 2016; 
Gultekin, Ozdilek, & Bestepe, 2014; Nègre-Pagès et al., 2010; Reijnders, Ehrt, 
Weber, Aarsland & Leentjens, 2008). Social Anxiety Disorder (SAD) is among 
the most prevalent anxiety disorders in PwIPD (Broen et al, 2016). Social 
anxiety is highly prevalent in people with visible differences, for example people 
who have a scar, mark or condition that makes their face or body look different 
(Rumsey, Clarke, & White, 2003). IPD could arguably be percieved as a 
condition that causes visible differences for some people. For example it can 
cause changes to posture, movement and facial expressions, all visible to 
others. Symptoms can also cause changes to competency with motor tasks 
such as walking, pouring a drink or speaking. Performance might be visibly 
different compared to other people and/or a persons own previous ability in 
these areas.  Although one could hypothesise that these visible objective 
differences might be related to the experience of social anxiety in some people 
with IPD (for example their beliefs about their symptoms and how they are 
perceived by others are distorted and exaggerated) this hasn’t been yet been 
explored in research. 
 
It has been highlighted in previous research that some items on general anxiety 
self-report measures overlap with symptoms of IPD. For example the Becks 
Anxiety Inventory (BAI), (Beck & Steer, 1993) contains hands trembling 
(Salazar, Le, Neargarder, & Cronin-Golomb, 2017). Such an aitem might reflect 
motor symptoms in IPD rather than or perhaps in addition to genuine symptoms 
of anxiety and therefore inflate scores. Therefore using these measures in the 
context of IPD might effect their validity, regardless if symptoms are objective or 
subjective in the context of self-report measures. This could also be true of 
social anxiety measures where some symptoms could be attributed to either 
social anxiety, IPD or some combination of the two. Clinical observations 
indicate that people with IPD are often aware that anxiety excaerbates their IPD 
symptoms but find it difficult to know how much of their experience is 
attributable to IPD and/or anxiety. Examples of items presenting ambiguity 
include references to sweating and trembling/shaking in the Social Phobia 
Inventory (Connor et al, 2000) and shaking/trembling and losing control in the 
Social Phobia Scale (Mattick & Clake, 1998). Performance related items such 
as I would get tense if I had to carry a tray across a crowded cafeteria and I 
would find it difficult if I had to drink something in a group of people in the Social 
Phobia Scale (Mattick & Clake, 1998) could also arguably be contaminated by 
the physical symptoms of IPD. Some measures such as The Liebowitz Social 
Anxiety Scale (LSAS) (Liebowitz, 1987) do not include such items and are 
situational based as opposed to perceived symptom or performance based.  
 
The numerous different anxiety measures used in the literature might contribute 
to the large variability in prevalence estimates across studies from 6%-55% 
(Broen et al., 2016). In relation to social anxiety in particular, Gultekin et al 
(2014) found that 42.5% of PwIPD met diagnostic criteria for SAD. This is 
higher than the 12% prevalence rate estimated in the general population (NICE, 
2013) and closer to the 30.6% reported in multiple sclerosis (MS), another 
neurodegenerative condition (Poder et al., 2009). Even after accounting for 
possible score inflation due to symptom overlap, Salazar et al (2017) 
demonstrated that anxiety scores remained high in PwIPD compared to the 
general population, indicating a need for closer clinical attention. Finding 
approaches to reduce stress and anxiety in IPD was identified as a top research 
priority by PwIPD (Deane et al., 2014). Most attention to date has been paid to 
depression in IPD. Although depression and anxiety are referred to in NICE 
clinical guidance for IPD, there is not yet acknowledgement that social anxiety is 
also a common problem in this population. 
 
Social Anxiety  
Social anxiety disorder (SAD) is characterised by a marked fear of one or more 
social situations that involves exposure to possible scrutiny from others (APA, 
2013). SAD is associated with poor quality of life (QoL) (Barrera & Norton, 
2009; Safren, Heimberg, Brown, & Holle, 1996). Cognitive Behavioural Therapy 
(CBT) is recommended as first line treatment (NICE, 2013) and is based upon 
two empirically supported cognitive-behavioural models (see Figure 1.1). 
 
Figure 1.1: Models of SAD 
 
 Common to both models in the maintenance of SAD are:  
1. Negative cognitions about oneself in social situations and the 
perception of the social situation as threatening. 
2. Safety-seeking behaviours (Salkovskis, 1991) such as total 
avoidance or more subtle avoidance to cope with the perceived 
threat. Safety seeking behaviours are often employed to conceal 
symptoms that are perceived to be observable and negatively 
judged by others. If objective symptoms are present as well as 
perceived symptoms, the severity of these and the perception of 
negative judgement by others is often largely overestimated.  
3. Attention to threat stimuli which feeds negative assumptions about 
how one appears to others. For example noticing a racing heart and 
feeling highly anxious may lead to the conclusion that one must 
also appear anxious. 
Although both models are conceptually similar, Clark & Wells place an 
emphasis on an internal, self-focus of attention that is interpreted as threatening 
whereas Heimberg, Brozovich & Rapee (2010) include attention to 
environmental cues that are interpreted as negative in addition. This study will 
focus on the Clark and Wells’ (1995) model primarily due to the operationalised 
measures available for the processes outlined above. Support for these models 
have been demonstrated in the general population (McManus, Sacadura, & 
Clark, 2008; Spurr & Stopa, 2002; Woody, Chambless, & Glass, 1997); young 
people (Ranta, Tuomisto, Kaltiala-Heino, Rantanen, & Marttunen, 2014; 
Schreiber, Höfling, Stangier, Bohn, & Steil, 2012) and support for CBT 
interventions based on these models have been demonstrated in the context of 
autism (Cardaciotto & Herbert, 2004); visible differences (Kleve, Rumsey, Wyn-
Williams, & White, 2002) and a single case study of social anxiety in IPD 
(Heinrichs, Hoffman, & Hoffman, 2001). These findings indicate that cognitive-
behavioural approaches to SAD may be widely generalisable to populations 
including PwIPD.      
 
Social anxiety in PwIPD 
SAD in the context of a medical condition was excluded from the Diagnostical 
and Statistical Manual (DSM) until its most recent revision (DSM-IV; APA, 
2013). Social anxiety in a medical context was regarded as having a different 
symptom profile, pathophysiology, demographic, course and treatment outcome 
compared with the general population (Heimberg et al., 2014). Therefore, 
existing cognitive-behavioural interventions for SAD were deemed potentially 
inappropriate, leading to a lack of understanding and support for social anxiety 
in these groups.  
 
Some have suggested that an association between anxiety and IPD severity 
indicates that anxiety in PwIPD is fundamentally different to that in the general 
population (e.g. Sagna, Gallo, & Pontone, 2014). Theories have explained the 
association as a result of pathological dopamine dysfunction (Moriyama et al., 
2011; Weintraub et al., 2005), i.e. that anxiety results from organic pathology. 
However not all studies have replicated this finding and some have found 
anxiety in PwIPD to be independent of disease severity (Brown & Fernie, 2015). 
As seen in MS (Wood et al., 2013) Brown & Fernie (2015) attributed anxiety in 
PwIPD largely to psychological variables. Some qualitative research findings 
are consistent with psychological explanations of anxiety in PwIPD. One finding 
showed that some PwIPD described feeling trapped in an unpredictable, 
unreliable body (Goddard, 2014). Another study showed that some PwIPD 
reported anxiety around others and a sense of being visibly different (Chen & 
Marsh, 2014) while other PwIPD reported fear and embarrassment regarding 
visible symptoms. For example some participants described worries that their 
tremor will cause them to spill food when eating (Goddard, 2014; Heinrichs et 
al., 2001). The way PwIPD thought about their symptoms (their metacognitions) 
was found to be a better predictor of anxiety than IPD symptom severity (Brown 
& Fernie, 2015; Fernie, Spada, Ray Chaudhuri, Klingelhoefer, & Brown, 2015). 
This finding indicates that a purely biomedical view of anxiety in PwIPD is 
inadequate. It suggests that psychosocial factors, particularly how symptoms 
are interpreted by an individual, are influential in an individual’s level of distress. 
A recent generic cognitive-behavioural model has attempted to describe how 
disease-related and psychosocial-related vulnerabilities interact in the 
development and maintenance of psychological distress including social anxiety 
in PwIPD (Stephens et al., 2018). It posits that the way PwIPD think, interpret 
and react to IPD influences anxiety. Though conceptually appealing, this model 
remains to be empirically tested, possibly due to a lack of available 
operationalised constructs. 
 
The current study aims to test the applicability of a specific cognitive-
behavioural conceptualisation of social anxiety in PwIPD. Negative social 
cognitions, safety seeking behaviours and focus of attention were chosen as 
key variables because they are common to both NICE recommended cognitive-
behavioural models and they have been operationalised. In line with the Clark & 
Wells (1995) model, the presence of internally focused attention in PwIPD 
during social interactions was included. Based on current literature, it was 
hypothesized that: 
(1a) Negative social cognitions, safety seeking behaviours and internally 
focused attention (cognitive behavioural variables) would all be positively 
associated with social anxiety in PwIPD.  
(1b) These cognitive-behavioural variables will account for a unique portion of 
variance in social anxiety in PwIPD even after accounting for demographic and 
IPD related variables.  
(2a) Social anxiety will be negatively associated with QoL in PwIPD.  





Participants and procedure 
Recruitment was supported by an NHS Movement Disorders Clinic in the South 
West and the charity Parkinson’s Disease UK. Both organisations shared study 
adverts with potential participants. Interested participants contacted the 
researcher who conducted a telephone screen to establish eligibility. Table 1.1 
below outlines exclusion criteria. Eligible participants completed informed 
consent and received their preference of either a paper questionnaire pack or 
link to an electronic version. If they were recruited via the clinic, they also had 
the option of face to face support. Participants were given researcher contact 
details for any clarification or technical support during participation. Some 
participants received practical support from a relative or carer to complete the 
study, however they were instructed to provide their own answers to the 
questions. Participants were given the option to have £2 donated to a relevant 
charity for their participation. The triple data collection strategy (online, post or 
in person) maximised recruitment in a potentially hard-to-reach population. The 
opportunity to take part remotely facilitated accessibility for participants across 
the UK who might otherwise be unable to attend face-to-face (e.g. due to high 
levels of social anxiety, physical impairment or resource limitations). 
 




This study used a cross-sectional design. Participants were asked to complete 
a battery of self-report measures at one time point. 
 
Sample size 
G*Power statistical software (version 3.41) was used to estimate sample size. 
The following assumptions were made: Linear multiple regression; Fixed Model 
R2; deviation from 0 Alpha of 0.05; power of 0.80; 9 predictors and a medium 
effect size (0.15) (based on Hodson et al (1995). The estimated required 
sample was 114 participants for the primary analysis.  
 
Demographics 
124 PwIPD took part. 52% were male. Participants were predominantly White 
British (95.9%). Most participants were aged between 51-79 (90.3%). 44.3% 
had been living with IPD for <5 years, 40.3% for 5-10 years, 12% for 11-15 
years and 0.8% >15 years. Over half (52.4%) reported mild-to-moderate IPD, 
37.9% reported moderate IPD and 9.7% moderate-to-severe IPD. 54.8% 
reported fluctuating IPD symptoms. 60% of the sample scored above the 
recommended clinical cut-off for social anxiety. 
 
Primary outcome variable 
The Liebowitz Social Anxiety Scale (LSAS) (Liebowitz, 1987) is a NICE 
recommended screening tool for social anxiety. Cronbach’s alpha is reported as 
0.95 indicating good internal consistency with test-retest reliability 0.83 at 12 
weeks (NICE, 2020). The self-report version (used in this study) correlates well 
with the original clinician reported version (Fresco et al., 2001). A cut-off of 
41/42 is reportedly the best balance between sensitivity (77.8%) and specificity 
(64.3%) for PwIPD (Kummer, Cardoso, & Teixeira, 2008) and was used to 
determine the prevalence of clinically relevant social anxiety in this sample.   
 
Secondary outcome variable 
The Quality of Life Index generic version (QLI) (Ferrans & Powers, 1985) 
measures quality of life and is reported to have good psychometric properties 
with Cronbach’s α ranging from 0.89-0.96 (Ferrans & Powers, 1992).  
 
Key predictor variables 
All key predictor variables have been used to test the applicability of a 
cognitive-behavioural understanding of social anxiety in other populations 
(Hodson, McMannus, Clark, & Doll, 2008; Schreiber et al., 2012). 
 
The Social Cognitions Questionnaire (SCQ) (Wells, Stopa, & Clark, 1993) 
measures the frequency and belief in negative social cognitions (only frequency 
was used in this study. This decision was based on limiting the number of 
variables in this study to essential core variables to reduce loss of power. If 
frequency of SCQ is found to be a relevant variable then further studies may 
wish to include percentage belief ratings. This would advance the research 
question from, are negative social cognitions present, to what influences the 
impact of negative social cognitions. Stopa (1995) is reported to have factor 
analysed data from 335 participants and established good internal consistency 
of this measure across three factors: negative self-beliefs α=.72, fear of 
performance failure α=.84 and fear of negative evaluation α=.81 (Stopa,1995 
unpublished data referred to in Tanner, Stopa & De Hower, 2006; Calvet, Orue, 
Hankin, 2013). For the purposes of this study, mean scores were used as 
recommended (Clark, 2005).  
 
The Social Behaviour Questionnaire (SBQ) (Clark, Wells, Salkovskis, & 
Hackmann, 1995) measures safety seeking behaviours in social situations. It 
has good internal consistency α = 0.8 and good discrimination between anxiety 
disorders (Clark, 2005). Mean scores were used as recommended (Clark, 
2005). 
 
The internal subscale of The Focus of Attention Questionnaire (FAQ) (Woody, 
1996) measures internally focused attention. It has acceptable internal 
consistency (Cronbach’s α =.76, (Woody et al., 1997)). The FAQ was modified 
by asking participants where they ‘usually’ focused their attention during a 
social interaction to fit the study design.  
 
Control variables 
The Movement Disorder Society Unified Parkinson’s Disease Rating Scale 
(MDS-UPDRS) was used as a measure of IPD severity and is considered to 
have good reliability and validity (Goetz. et al., 2008). It has a reliable factor 
structure supporting the use of each part separately with the lowest Cronbach’s 
α reported to be .79 (Goetz. Et al., 2008). Only self-report items in parts I and II 
were used in this study to fit the study design. Self-report items of NMS severity 
(Part I) and motor symptom severity (Part II) significantly model clinician rated 
reports, suggesting patient perceptions of disability represent valid estimates of 
symptom severity (Goetz, Luo, & Stebbins., 2019). Recommended motor 
symptom severity cut-off scores are: mild/moderate, 12/13 and 
moderate/severe, 28/29 (Martínez-Martín et al., 2015). These cut-offs were 
used to establish IPD severity in the sample. Part II has appropriate 
performance in assessing IPD disability compared to other measures 
(Rodríguez-Blázquez et al., 2017).  
 
The Hospital Anxiety and Depression Scale (HADS) (Zigmond & Snaith, 1983) 
was used to assess anxiety and depression. It is shown to have satisfactory 
psychometric properties in PwIPD (Anxiety subscale Cronbach’s α = 0.86; 
depression subscale α = 0.78) (Marinus, Leentjens, Visser, Stiggelbout, & van 
Hilten, 2002).  
 
Statistical Analysis  
IBM SPSS statistics version 25 was the statistical software package used to 
perform a 3-step hierarchical linear regression with social anxiety as the 
dependent variable (Table 1.3). In step 1 the effects of age, sex, depression 
and anxiety were controlled for due to associations with anxiety in previous 
literature (Bolluk, Ozel-Kizil, Akbostanci, & Atbasoglu, 2010). Age was not 
entered into the model after observing insufficient evidence for a linear 
relationship with social anxiety (see Table 1.2). In step 2, NMS and motor 
symptom severity were controlled for due to their possible associations with 
anxiety (Sagna et al., 2014). In step 3 cognitive-behavioural variables were 
entered. A second hierarchical regression was conducted with QoL as the 
dependent variable: Anxiety and depression were entered in step 1, IPD 
variables were entered in step 2 and social anxiety was entered in the final 
step. The final model is reported (Table 1.4). 
 
Missing Data  
Guidance on handling missing items was followed for each measure where 
available. SCQ, SBQ and QLI mean scores were calculated which automatically 
deals with missing items. As recommended, no more than one item from part I 
or two items from part II of the MDS-UPDRS was pro-rated (Goetz et al., 2015). 
Mean imputation was applied when no more than 20% of items were missing 
(Enders, 2003). Where more than 20% of items were missing, data were 
removed. See table 1.5 below for a breakdown of missing data across each 
measure. To maximise use of data, cases were excluded pairwise during 
statistical analysis (Pallant, 2010).  
 
Table 1.5: Missing data 
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Results   
 
Parametric Assumptions 
Spearman rho correlations (Table 1.2) were used to assess all bivariate 
relationships. Tolerance (0.409-0.936) and Variance Inflation Factor (VIF) 
values (1.069-2.445) for all predictors fell within acceptable thresholds 
suggesting no evidence of multicollinearity (Pallant, 2010). Visual inspection of 
a histogram, normal P-P plot and scatter plot of standardised residuals 
indicated no evidence that parametric assumptions were violated (Field, 2013).
 
Table 1.2: Spearman’s Rho Correlation Matrix 
Hypothesis 1a 
Spearman’s Rho correlations indicated moderate-to-strong positive linear 
relationships between each cognitive-behavioural variable and social anxiety. 
Results indicated support for hypotheses 1. The association between social anxiety 
and negative social cognitions was strong (Rs= .772, N=122, P<0.001), moderate 
with safety-seeking behaviours (Rs= .694, N=123, P<0.001) and moderate with an 
internal focus of attention (Rs=.511, N=119, P<0.001). 
      
Hypothesis 1b  
The hypothesis that each cognitive-behavioural factor would explain a unique portion 
of variance in social anxiety was partly supported. Hierarchical linear regression 
(Table 1.3) indicated that cognitive-behavioural factors accounted for 43.5% of 
variance in social anxiety in PwIPD. The final model accounted for 71.6% of variance 
overall and was statistically significant (F=32.10, df=8, 102, p<0.001). Negative 
social cognitions (t (102) =7.30, p<.001) and safety-seeking behaviours (t (102) 
=4.19, p<.001) were statistically significant predictors however an internal focus of 
attention (t (102) = -.70, p=.677) was not.  
 
IPD NMS severity (t(102)= -2.47, p=.015) and depression, (t(102)= 2.25, p=.026) 
were significant predictors of social anxiety however motor symptoms (t(102)= 1.97, 
p=.051), sex (t(102)=1.26, p=.21) and anxiety (t(102)= -.53, p=.60) were not. 
  
Table 1.3: Hierarchical Regression Model with Social Anxiety (LSAS) as the outcome variable 
 
Hypothesis 2a  
Spearman’s Rho correlations indicated a weak negative linear association between 
social anxiety and QoL providing some support for this hypothesis (Rs= -.39, N=116, 
p<.01).  
 
Hypothesis 2b  
The hypothesis that social anxiety would explain a unique portion of variance in QoL 
was not supported. Hierarchical regression indicated that social anxiety was not 
predictive of QoL in PwIPD (t (106) = -1.65, p=.10). The final model (Table 1.4) 
which accounted for 38.8% of the variance in QoL indicated that only depression and 
NMS made significant contributions to the model. Anxiety, motor symptoms and 
social anxiety did not. This model was statistically significant (F=13.45, df=5, 106, 
p<.01).  
 




This is the first study to demonstrate that negative social cognitions and safety-
seeking behaviours are strongly associated with social anxiety in PwIPD. Social 
anxiety was more strongly correlated with negative social cognitions and safety-
seeking behaviours than symptoms of IPD severity. When the influence of other 
relevant factors were statistically controlled for, both negative social cognitions and 
safety seeking behaviours predicted unique variance in social anxiety in PwIPD. 
Internally focused attention did not. Social anxiety was not predicted by motor 
symptoms and NMS were a very weak predictor.  
These findings are consistent with the theoretical position that psychological factors 
are influential to the experience of social anxiety in PwIPD. Results indicate that a 
cognitive-behavioural understanding of social anxiety may be a useful conceptual 
framework in PwIPD. This contrasts with a purely biomedical disease model and is 
consistent with existing evidence that psychological factors play a role in influencing 
distress in PwIPD (Brown & Fernie, 2015; Fernie et al., 2015).  
 
Negative social cognitions were the strongest predictor of social anxiety while motor 
symptom severity did not predict any variance in the final model. This study did not 
specifically look at individual interpretations of IPD symptoms. However given the 
initial finding that negative social cognitions are associated with social anxiety in 
PwIPD, it might be a reasonable next step to tentatively hypothesis that the way 
someone interprets their IPD symptoms, has an impact on their behaviour and 
experience of social anxiety. It would be useful to gain a fuller understanding on what 
the content of their negative social cognitions are and what are the specific safety 
seeking behaviours PwIPD are using to cope. For future research to test this 
hypothesis adequately, the subjective interpretations of IPD symptoms from self-
report measures would have to be compared against an objective measure of IPD 
symptom severity. Completing the full MDS-UPDRS alongside a gold standard 
measure of social anxiety based on the DSM-IV or ICD criteria as well as a semi-
structured interview schedule to capture a detailed account of how each participant 
interprets their symptoms of IPD would be one way to achieve this. It would enable a 
fuller understanding of common cognitive biases that may be present in this 
population that would be useful for clinicians working with PwIPD to be mindful of. 
 
This is the first study to demonstrate that the degree to which a PwIPD engages in 
safety-seeking behaviours (e.g. putting one’s hand in a pocket to hide a tremor) is 
moderately predictive of social anxiety. This is consistent with a cognitive-
behavioural understanding of SAD, where thoughts about oneself can drive 
behavioural responses intended to reduce social anxiety but actually exacerbate it. 
Future research would also benefit from measuring a more detailed account of the 
safety seeking behaviours PwIPD use and whether these are carried out in response 
to particular IPD symptoms. This would allow a richer understanding of how PwIPD 
use safety seeking behaviours and help inform clinicians working with PwIPD of what 
to be mindful of in this context. 
 
The finding that depression and NMS were predictive of social anxiety in IPD was 
consistent with previous literature (Bolluk et al., 2010). The finding that motor 
symptom severity was not predictive of social anxiety was also consistent with 
previous literature in PwIPD (Brown & Fernie, 2015).  
 
The association between NMS and social anxiety in this study was not predicted. 
One possible explanation is symptoms overlap. For example, question 1.9 in the 
MDS-UPDRS part I asks about pain and other sensations such as uncomfortable 
feelings in the body like tingling. Another explanation is that NMS such as urinary 
problems or fainting are interpreted as more socially threatening than motor 
symptoms. Future qualitative studies could explore PwIPD interpretations of NMS 
and motor symptoms to gain insight into this finding and develop a more IPD specific 
understanding of social anxiety.  
 
The finding that social anxiety shared a negative linear relationship with QoL was 
consistent with previous literature (Barrera & Norton, 2009; Safren et al., 1996). 
Although this was predicted, the association was weak and social anxiety did not 
predict QoL. Findings therefore suggest that depression and NMS might be more 
important factors when considering QoL in PwIPD. It is also possible that variance 
shared by depression and social anxiety might have masked a more complex 
relationship reflecting a limitation of the sensitivity and specificity of the measures 
used in this study.  
 
As expected, the prevalence of social anxiety in this sample was high with 60% 
scoring above the clinical cut-off. This is higher than the prevalence in the general 
population, other samples of PwIPD and people with other movement disorders such 
as MS (Gultekin et al., 2014; Poder et al., 2009). Sampling bias to a study designed 
to explore SAD in PwIPD and a screening tool to assess social anxiety could have 
contributed to this high prevalence. Even so, such high prevalence in this sample 
supports the argument that SAD is a clinically relevant problem for PwIPD warranting 
further attention.  
 
Contrary to Schreiber et al (2012) and Hodson et al (2008), an internal focus of 
attention did not predict social anxiety in this study. While this might represent a 
genuine finding it might also be due to methodology. This study adapted the FAQ 
from situation specific to generic questions to fit the non-experimental design. This 
may have impacted recall accuracy. The importance of an internal focus of attention 
to social anxiety in PwIPD could be clarified by using the original FAQ questions and 
directing participants to focus on a specific recent social interaction via semi-
structured interview in future research. Another possible explanation could be the 
regression analysis which involved entering all cognitive-behavioural variables during 
the same step. This could have led to an overlap of variance accounted for between 
the 3 predictors masking the unique contributions of self-focused attention. One way 
to test this in future studies would be to enter cognitive-behavioural variables in a 
hypothesis led step wise way in line with cognitive models.   
 
Limitations 
The cross-sectional design means that causality cannot be inferred limiting the 
conclusions that can be drawn about associations in this study. All data in this study 
was self-reported, a necessary strategy to maximise recruitment in a hard-to-reach 
population. Truly objective estimates of IPD symptom severity were thus not 
achieved, limiting conclusions about the relationship between social anxiety, NMS 
and motor symptoms of IPD. Self-report alone prevents elimination of the possible 
contamination of cognitive biases that could have otherwise been ruled out by 
contrast with clinician ratings. Although Goetz, Luo & Stebbins (2019) indicate that 
self-report items on the MDS-UPDRS correlate well with clinician reported items, 
future research would benefit from controlling more robustly for the potential 
cognitive bias of symptoms of IPD by using the full MDS-UPDRS.  
 
This sample consisted largely of PwIPD who had an interest in research. Evidence 
suggests volunteer bias can influence outcomes that aren’t representative more 
generally (Jordan et al., 2013). Therefore caution should be drawn about 
generalising the findings of this study. While the sample was geographically diverse, 
non-white British and severe levels of IPD were under-represented. This could be 
related to the online recruitment strategy and inclusion criteria which attracted 
younger, therefore on average people in earlier stages of disease. PwIPD in earlier 
stages are more likely to be adjusting to their diagnosis and the challenges IPD 
brings to their identity in different social circumstances. For example, they may still 
be working and have an active role in larger social networks that might challenge 
their functional abilities. Arguably they might therefore experience a heightened level 
of self-consciousness compared to people in latter stages, who may be more 
adjusted making social anxiety less relevant. Assessment of social anxiety 
experiences among people with severe IPD would deepen our understanding of 
social anxiety across the course of IPD.  
 
Clinical implications 
These findings are consistent with the revision in the DSM-5 which now accepts that 
people within a medical context may also meet criteria for SAD (Heimberg et al., 
2014). As we know from other medical conditions, how an individual interprets their 
disability is a critical part of their distress and experience, regardless of how their 
disability may ‘objectively’ appear when measured clinically or using standardised 
tools.  
 
This study thus partially supports the applicability of a cognitive-behavioural 
understanding of social anxiety in PwIPD. In practice, assessment of a PwIPD’s 
interpretation of their IPD should be regarded as equally important to the 
assessment of disability or disease ‘severity’. Anxiety cannot be assumed to be 
linearly associated with disease progression or ‘organic pathology’. Clinicians should 
pay attention to any such incongruence and consider referral for psychological 
intervention when social anxiety levels are high.  
 
Such interventions may include Cognitive Behavioural Therapy (CBT) particularly if 
there are clear cognitive biases and safety-seeking behaviours likely to maintain 
anxiety. However, further research must clarify which processes from the available 
models would be most applicable for PwIPD. For example combining the key 
processes from disorder specific models such as Clark & Wells (1995) and Heimberg 
(1997) with a more generic context that acknowledges the vulnerabilities that arise 
due to IPD such as those proposed by Stephens et al (2018) might offer more 
tailored interventions for PwIPD and social anxiety. Such an approach offers great 




This novel study provides evidence that negative social cognitions and safety-
seeking behaviours are cognitive-behavioural variables that are associated with and 
predictive of social anxiety in PwIPD. Results are similar to what we might expect to 
see in the general population. Interpretations and reactions to IPD symptoms and the 
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